Comparison of two strategies to reduce the pain associated with intravenous administration of rocuronium.
Phase 4
- Registration Number
- CTRI/2009/091/000002
- Lead Sponsor
- Dr. Ashish Jain
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 120
Inclusion Criteria
Patients of both sexes of ASA grade 1 & 2, Age 18-55 years, Patients undergoing general anesthesia for elective general, gynaecologic, orthopaedic, urologic, plastic, spine, ophthalmic, ENT surgeries
Exclusion Criteria
(1)Age less than18 years or more than 55 years.
(2)ASA grade 3 or more.
(3)Patients with history of allergy to study medications.
(4)Patients with any psychiatric illness.
(5)Patients receiving analgesics or sedatives.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Mechanism rocuronium injection pain histamine release bradykinin venous irritation anesthesia
Lidocaine pretreatment versus dilution reducing rocuronium injection pain systematic review meta-analysis
Comparison injection pain reduction strategies rocuronium vecuronium cisatracurium neuromuscular blockers
Priming principle versus lidocaine admixture efficacy reducing rocuronium injection pain anesthesia
Management strategies rocuronium induced injection pain clinical practice guidelines anesthesiology